Amide proton transfer (APT) imaging is an emerging chemical exchange saturation transfer (CEST)-based MRI technique that is sensitive to mobile proteins and peptides in tissue and has drawn considerable attention in the field of cellular and molecular imaging. In the present work, our result demonstrates that it is feasible to use APT imaging for Bladder Cancer (BCa) and it has shown great potential for bladder cancer imaging, thus opening new research avenues in this field.
This abstract and the presentation materials are available to members only; a login is required.